STAT+: A Merck cancer drug to watch

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Morning! The impact of President Trump’s “most-favored nation” drug-pricing push can be hard to decipher, but the policy is starting to look less like a slogan and more like a real pressure point that could mean higher prices abroad.

Meanwhile, 93-year-old vaccine legend Stanley Plotkin is watching vaccination rates slip and calling the anti-vaccine turn inside government what he thinks it is: “stupid” and “immoral.” Also, a pointed warning about at-home ketamine oversight and Novartis reaches a quiet settlement in the Henrietta Lacks case.

Continue to STAT+ to read the full story…